[1]
P. I. Karakiewicz, “Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials”, CUAJ, vol. 12, no. 6, pp. 173–80, Mar. 2018.